PO-41 - Rivaroxaban is effective therapy for high risk...

Thrombosis Research 2016 / 04 Vol. 140

PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease

Wells, P.S., Theberge, I.A., Bowdridge, J.C., Forgie, M.A., Carrier, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
140
Language:
english
Journal:
Thrombosis Research
DOI:
10.1016/S0049-3848(16)30174-8
Date:
April, 2016
File:
PDF, 65 KB
english, 2016
Conversion to is in progress
Conversion to is failed